Cue Health (HLTH) Stock Forecast, Price Target & Predictions
HLTH Stock Forecast
Cue Health stock forecast is as follows: an average price target of $8.00 (represents a 114185.71% upside from HLTH’s last price of $0.01) and a rating consensus of 'Hold', based on 1 wall street analysts offering a 1-year stock forecast.
HLTH Price Target
The average price target for Cue Health (HLTH) is $8.00 based on 1-year price targets from 1 Wall Street analysts in the past 3 months, with a price target range of $8.00 to $8.00. This represents a potential 114185.71% upside from HLTH's last price of $0.01.
HLTH Analyst Ratings
According to 1 Wall Street analysts, Cue Health's rating consensus is 'Hold'. The analyst rating breakdown for HLTH stock is 0 'Strong Buy' (0.00%), 0 'Buy' (0.00%), 1 'Hold' (100.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Cue Health Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Aug 11, 2022 | Morgan Stanley | - | - | 61.29% | 114185.71% | |
| May 12, 2022 | Morgan Stanley | - | - | 90.47% | 142757.14% |
The latest Cue Health stock forecast, released on Aug 11, 2022 by Morgan Stanley company, set a price target of $8.00, which represents a 61.29% increase from the stock price at the time of the forecast ($4.96), and a 114185.71% increase from HLTH last price ($0.01).
Cue Health Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | - | - |
| Avg Price Target | - | - | - |
| Last Closing Price | $0.01 | $0.01 | $0.01 |
| Upside/Downside | -100.00% | -100.00% | -100.00% |
In the current month, the average price target of Cue Health stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Cue Health's last price of $0.01. This month's average price target is down NaN% compared to last quarter, and down NaN% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Aug 11, 2022 | Morgan Stanley | Equal-Weight | Equal-Weight | Hold |
| May 12, 2022 | Morgan Stanley | Equal-Weight | Equal-Weight | Hold |
Cue Health's last stock rating was published by Morgan Stanley on Aug 11, 2022. The company gave HLTH a "Equal-Weight" rating, the same as its previous rate.
Cue Health Financial Forecast
Cue Health Revenue Forecast
| Dec 25 | Oct 25 | Jul 25 | Mar 25 | Dec 24 | Oct 24 | Jul 24 | Mar 24 | Dec 23 | Oct 23 | Jul 23 | Mar 23 | Dec 22 | Oct 22 | Jul 22 | Mar 22 | Dec 21 | Oct 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | $18.80M | - | - | $24.49M | $146.78M | - | - | $177.45M | $192.51M | - |
| Avg Forecast | $31.80M | $23.40M | $19.00M | $25.80M | $26.32M | $15.73M | $9.40M | $10.10M | $17.68M | $11.81M | $8.92M | $23.02M | $47.78M | $58.17M | $52.91M | $175.15M | $190.66M | $200.32M |
| High Forecast | $31.80M | $23.40M | $19.00M | $25.80M | $26.32M | $15.73M | $9.40M | $10.10M | $17.68M | $11.81M | $8.92M | $23.02M | $47.78M | $58.17M | $52.91M | $175.15M | $190.66M | $200.32M |
| Low Forecast | $31.80M | $23.40M | $19.00M | $25.80M | $26.32M | $15.73M | $9.40M | $10.10M | $17.68M | $11.81M | $8.92M | $23.02M | $47.78M | $58.17M | $52.91M | $175.15M | $190.66M | $200.32M |
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Surprise % | - | - | - | - | - | - | - | - | 1.06% | - | - | 1.06% | 3.07% | - | - | 1.01% | 1.01% | - |
Cue Health's average Quarter revenue forecast for Mar 24 based on 1 analysts is $10.10M, with a low forecast of $10.10M, and a high forecast of $10.10M. HLTH's average Quarter revenue forecast represents a -46.25% decrease compared to the company's last Quarter revenue of $18.80M (Dec 23).
Cue Health EBITDA Forecast
| Dec 25 | Oct 25 | Jul 25 | Mar 25 | Dec 24 | Oct 24 | Jul 24 | Mar 24 | Dec 23 | Oct 23 | Jul 23 | Mar 23 | Dec 22 | Oct 22 | Jul 22 | Mar 22 | Dec 21 | Oct 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| EBITDA | - | - | - | - | - | - | - | - | $-50.06M | - | - | $-86.11M | $-36.59M | - | - | $13.46M | $30.10M | - |
| Avg Forecast | $-20.38M | $-15.00M | $-12.18M | $-16.53M | $-16.86M | $-10.08M | $-6.02M | $-6.47M | $-11.33M | $-7.57M | $-5.72M | $-14.75M | $-30.62M | $-37.28M | $-33.91M | $29.07M | $-122.18M | $77.13M |
| High Forecast | $-20.38M | $-15.00M | $-12.18M | $-16.53M | $-16.86M | $-10.08M | $-6.02M | $-6.47M | $-11.33M | $-7.57M | $-5.72M | $-14.75M | $-30.62M | $-37.28M | $-33.91M | $34.89M | $-122.18M | $92.55M |
| Low Forecast | $-20.38M | $-15.00M | $-12.18M | $-16.53M | $-16.86M | $-10.08M | $-6.02M | $-6.47M | $-11.33M | $-7.57M | $-5.72M | $-14.75M | $-30.62M | $-37.28M | $-33.91M | $23.26M | $-122.18M | $61.70M |
| Surprise % | - | - | - | - | - | - | - | - | 4.42% | - | - | 5.84% | 1.20% | - | - | 0.46% | -0.25% | - |
1 analysts predict HLTH's average Quarter EBITDA for Jul 22 to be $-33.91M, with a high of $-33.91M and a low of $-33.91M. This is -351.92% lower than Cue Health's previous annual EBITDA (Mar 22) of $13.46M.
Cue Health Net Income Forecast
| Dec 25 | Oct 25 | Jul 25 | Mar 25 | Dec 24 | Oct 24 | Jul 24 | Mar 24 | Dec 23 | Oct 23 | Jul 23 | Mar 23 | Dec 22 | Oct 22 | Jul 22 | Mar 22 | Dec 21 | Oct 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Net Income | - | - | - | - | - | - | - | - | $-148.43M | - | - | $-92.77M | $-31.51M | - | - | $2.80M | $34.23M | - |
| Avg Forecast | $-39.66M | $-41.25M | $-44.42M | $-47.59M | $-26.97M | $-28.55M | $-30.14M | $-59.75M | $-67.82M | $-70.33M | $-81.43M | $-96.37M | $-85.75M | $-86.06M | $-73.37M | $6.05M | $17.10M | $23.76M |
| High Forecast | $-39.66M | $-41.25M | $-44.42M | $-47.59M | $-26.97M | $-28.55M | $-30.14M | $-59.75M | $-61.79M | $-70.33M | $-81.43M | $-96.37M | $-85.75M | $-86.06M | $-73.37M | $7.27M | $17.10M | $28.51M |
| Low Forecast | $-39.66M | $-41.25M | $-44.42M | $-47.59M | $-26.97M | $-28.55M | $-30.14M | $-59.75M | $-72.34M | $-70.33M | $-81.43M | $-96.37M | $-85.75M | $-86.06M | $-73.37M | $4.84M | $17.10M | $19.01M |
| Surprise % | - | - | - | - | - | - | - | - | 2.19% | - | - | 0.96% | 0.37% | - | - | 0.46% | 2.00% | - |
Cue Health's average Quarter net income forecast for Jul 22 is $-73.37M, with a range of $-73.37M to $-73.37M. HLTH's average Quarter net income forecast represents a -2717.50% decrease compared to the company's last Quarter net income of $2.80M (Mar 22).
Cue Health SG&A Forecast
| Dec 25 | Oct 25 | Jul 25 | Mar 25 | Dec 24 | Oct 24 | Jul 24 | Mar 24 | Dec 23 | Oct 23 | Jul 23 | Mar 23 | Dec 22 | Oct 22 | Jul 22 | Mar 22 | Dec 21 | Oct 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| SG&A | - | - | - | - | - | - | - | - | $16.09M | - | - | $28.19M | $38.47M | - | - | $61.08M | $44.65M | - |
| Avg Forecast | $24.20M | $17.81M | $14.46M | $19.63M | $20.03M | $11.97M | $7.15M | $7.69M | $13.46M | $8.99M | $6.79M | $17.52M | $36.36M | $44.27M | $40.27M | $131.93M | $145.10M | $47.47M |
| High Forecast | $24.20M | $17.81M | $14.46M | $19.63M | $20.03M | $11.97M | $7.15M | $7.69M | $13.46M | $8.99M | $6.79M | $17.52M | $36.36M | $44.27M | $40.27M | $158.31M | $145.10M | $56.96M |
| Low Forecast | $24.20M | $17.81M | $14.46M | $19.63M | $20.03M | $11.97M | $7.15M | $7.69M | $13.46M | $8.99M | $6.79M | $17.52M | $36.36M | $44.27M | $40.27M | $105.54M | $145.10M | $37.97M |
| Surprise % | - | - | - | - | - | - | - | - | 1.20% | - | - | 1.61% | 1.06% | - | - | 0.46% | 0.31% | - |
Cue Health's average Quarter SG&A projection for Mar 24 is $7.69M, based on 1 Wall Street analysts, with a range of $7.69M to $7.69M. The forecast indicates a -52.22% fall compared to HLTH last annual SG&A of $16.09M (Dec 23).
Cue Health EPS Forecast
| Dec 25 | Oct 25 | Jul 25 | Mar 25 | Dec 24 | Oct 24 | Jul 24 | Mar 24 | Dec 23 | Oct 23 | Jul 23 | Mar 23 | Dec 22 | Oct 22 | Jul 22 | Mar 22 | Dec 21 | Oct 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| EPS | - | - | - | - | - | - | - | - | $-0.96 | - | - | $-0.61 | $-0.21 | - | - | $0.02 | $0.23 | - |
| Avg Forecast | $-0.25 | $-0.26 | $-0.28 | $-0.30 | $-0.17 | $-0.18 | $-0.19 | $-0.38 | $-0.43 | $-0.44 | $-0.51 | $-0.61 | $-0.54 | $-0.54 | $-0.46 | $-0.05 | $0.11 | $1.40 |
| High Forecast | $-0.25 | $-0.26 | $-0.28 | $-0.30 | $-0.17 | $-0.18 | $-0.19 | $-0.38 | $-0.39 | $-0.44 | $-0.51 | $-0.61 | $-0.54 | $-0.54 | $-0.46 | $-0.05 | $0.11 | $1.40 |
| Low Forecast | $-0.25 | $-0.26 | $-0.28 | $-0.30 | $-0.17 | $-0.18 | $-0.19 | $-0.38 | $-0.46 | $-0.44 | $-0.51 | $-0.61 | $-0.54 | $-0.54 | $-0.46 | $-0.05 | $0.11 | $1.40 |
| Surprise % | - | - | - | - | - | - | - | - | 2.25% | - | - | 1.00% | 0.39% | - | - | -0.38% | 2.13% | - |
According to 1 Wall Street analysts, Cue Health's projected average Quarter EPS for Jul 22 is $-0.46, with a low estimate of $-0.46 and a high estimate of $-0.46. This represents a -2412.50% decrease compared to HLTH previous annual EPS of $0.02 (Mar 22).
Cue Health Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| HLTH | Cue Health | - | - | 19900.00% | Hold |
| AKLI | Akili | - | - | 655.81% | Buy |
| CMAX | CareMax | - | - | 288.06% | Hold |
| HCAT | Health Catalyst | - | - | 281.85% | Buy |
| FORA | Forian | - | - | 115.31% | Buy |
| CERT | Certara | - | - | 97.85% | Buy |
| HCTI | Healthcare Triangle | - | - | 86.92% | Buy |
| PINC | Premier | - | - | 48.31% | Hold |
| AUGX | Augmedix | - | - | 13.62% | Hold |
| HQY | HealthEquity | - | - | -7.31% | Buy |
| HSTM | HealthStream | - | - | -8.86% | Buy |